| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1320007 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ETV5 mRNA | CTD | PMID:22079256 |
| 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of ETV5 mRNA | CTD | PMID:21983209 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1320007 | 6480464 | Ethinyl Estradiol affects the expression of ETV5 mRNA | CTD | PMID:20170705 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1320007 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ETV5 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1320007 | 6480464 | Estradiol results in increased expression of ETV5 mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | increases expression | ISO | RGD:1320007 | 6480464 | Estradiol results in increased expression of ETV5 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1320007 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ETV5 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1623051 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ETV5 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1623051 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ETV5 mRNA | CTD | PMID:19933214 PMID:21354282 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1623051 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ETV5 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1623051 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ETV5 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1320007 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ETV5 mRNA | CTD | PMID:19619570 |
| 2-methylcholine | affects expression | ISO | RGD:1320007 | 6480464 | beta-methylcholine affects the expression of ETV5 mRNA | CTD | PMID:21179406 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1623051 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ETV5 mRNA | CTD | PMID:20188158 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1623051 | 6480464 | Methylcholanthrene results in increased expression of ETV5 mRNA | CTD | PMID:20713471 |
| 4-vinylcyclohexene dioxide | affects expression | ISO | RGD:1623051 | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of ETV5 mRNA | CTD | PMID:20829426 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:1320007 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ETV5 mRNA | CTD | PMID:22079614 |
| aflatoxin B1 | decreases expression | ISO | RGD:1623051 | 6480464 | Aflatoxin B1 results in decreased expression of ETV5 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:1320007 | 6480464 | Aflatoxin B1 results in increased expression of ETV5 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1320007 | 6480464 | Tretinoin results in decreased expression of ETV5 mRNA | CTD | PMID:16054129 |
| astemizole | decreases expression | EXP | | 6480464 | Astemizole results in decreased expression of ETV5 mRNA | CTD | PMID:20221588 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1623051 | 6480464 | Benzo(a)pyrene results in decreased expression of ETV5 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1320007 | 6480464 | Benzo(a)pyrene results in decreased expression of ETV5 mRNA | CTD | PMID:22316170 |
| bisphenol A | affects expression | ISO | RGD:1320007 | 6480464 | bisphenol A affects the expression of ETV5 mRNA | CTD | PMID:20170705 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of ETV5 mRNA | CTD | PMID:19167457 |
| cobalt dichloride | decreases expression | ISO | RGD:1320007 | 6480464 | cobaltous chloride results in decreased expression of ETV5 mRNA | CTD | PMID:19376846 |
| copper(2+) sulfate | increases expression | ISO | RGD:1320007 | 6480464 | Copper Sulfate results in increased expression of ETV5 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | ISO | RGD:1320007 | 6480464 | Cyclosporine results in increased expression of ETV5 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1623051 | 6480464 | Cyclosporine results in increased expression of ETV5 mRNA | CTD | PMID:19770486 |
| dibutyl phthalate | increases expression | ISO | RGD:1623051 | 6480464 | Dibutyl Phthalate results in increased expression of ETV5 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1623051 | 6480464 | Dibutyl Phthalate results in increased expression of ETV5 mRNA | CTD | PMID:17361019 PMID:21266533 |
| methoxychlor | affects expression | ISO | RGD:1623051 | 6480464 | Methoxychlor affects the expression of ETV5 mRNA | CTD | PMID:20829426 |
| paracetamol | increases expression | ISO | RGD:1320007 | 6480464 | Acetaminophen results in increased expression of ETV5 mRNA | CTD | PMID:21420995 |
| phenobarbital | affects expression | ISO | RGD:1320007 | 6480464 | Phenobarbital affects the expression of ETV5 mRNA | CTD | PMID:19159669 |
| sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of ETV5 mRNA | CTD | PMID:22561333 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1320007 | 6480464 | tert-Butylhydroperoxide results in increased expression of ETV5 mRNA | CTD | PMID:15336504 |
| valproic acid | decreases expression | ISO | RGD:1623051 | 6480464 | Valproic Acid analog results in decreased expression of ETV5 mRNA; more ... | CTD | PMID:21427059 |